Results 81 to 90 of about 53,232 (175)

Acute Angina in Anomalous Left Main Coronary Artery With Prepulmonic Course: A Case Report

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Although a prepulmonic left main coronary artery is usually considered a lower‐risk AAOCA subtype, it may still be associated with acute ischemic symptoms when significant atherosclerotic coronary artery disease is present. Multimodality imaging is essential for defining the coronary anatomy, and coronary artery bypass grafting may be the ...
Mohammad Rouzbahani, Sepehr Navabifar, Nafiseh Montazeri, Amirmasoud Rahimi, Alireza Hayati   +4 more
wiley   +1 more source

Impact of Evolocumab on LDL‐Cholesterol and Cardiovascular Outcomes in Patients With Established CVD: Systematic Review and Meta‐Analysis

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 6, November 2026.
A systematic review and meta‐analysis of 9 randomised controlled trials (67,662 patients) found that evolocumab significantly improved lipid parameters and reduced major adverse cardiovascular events, myocardial infarction, and coronary revascularisation.
Anika Goel, Muhammad Abdullah Naveed, Hemeesh Tandel, Affaf Mahmood, Muhammad Mukhlis, K. Sai Varun Reddy, Arun Kumar Maloth, Anchit Chauhan, Ameer Awashra, Amogh Verma, Haris Bin Tahir   +10 more
wiley   +1 more source

Validation of a Novel, Low‐Cost, Portable MRI‐Compatible Exercise Device in Healthy Volunteers and Patients With Pulmonary Hypertension

NMR in Biomedicine, Volume 39, Issue 11, November 2026.
We developed a simple, low‐cost MR‐compatible exercise device as an alternative to commercial ergometers. In this proof‐of‐concept study, it evoked a robust stress response during MR‐augmented cardiopulmonary exercise testing and distinguished pulmonary arterial hypertension patients from healthy controls.
Ruta Virsinskaite, James T. Brown, Tushar Kotecha, Darren Bower, Jennifer A. Steeden, Javier Montalt‐Tordera, Olivier Jaubert, Marianna Fontana, J. Gerry Coghlan, Daniel S. Knight, Vivek Muthurangu   +10 more
wiley   +1 more source

Does COVID‐19 Vaccination Protect Against Post‐COVID Cardiovascular Conditions?

Reviews in Medical Virology, Volume 36, Issue 6, November 2026.
ABSTRACT Cardiovascular diseases, such as acute myocardial infarction, heart failure, and arrhythmias, have been associated with SARS‐CoV‐2 infection, representing an important cause of long‐term morbidity and mortality. In addition to preventing primary infection, COVID‐19 vaccination has emerged as a protective factor against post‐COVID ...
Lidian Franci Batalha Santa Maria, Márcio Coutinho Xavier Naves, Elisabeth Carmen Duarte, Isis Polianna Silva Ferreira de Carvalho, Henry Maia Peixoto   +4 more
wiley   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 9, Page 1219-1233, November 2026.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Clinical characteristics and in‐hospital mortality among insulin pump users with acute coronary syndrome in the predominantly open‐loop era: A UK‐wide MINAP registry analysis

Diabetic Medicine, Volume 43, Issue 11, November 2026.
Abstract Background We compared characteristics of adults with insulin‐treated diabetes using continuous subcutaneous insulin infusion (CSII) versus multiple daily insulin injections (MDI) during admission with acute coronary syndrome (ACS) and identified factors associated with in‐hospital mortality among CSII users.
Harshal Deshmukh, Moosa Shaikh, Emma G. Wilmot, Eric Kilpatrick, Sudipta Chattopadhyay, Thozhukat Sathyapalan, Joseph John   +6 more
wiley   +1 more source

Correction of aggregative thrombocytes activity in patients with unstable angina by THz irradiation of nitrogen oxide occurrence at in vitro conditions

Russian Open Medical Journal, 2013
There had been shown a normalizing effect of THz radiation of MEAS (molecular emission and absorption spectrum) of 400 GHz nitrogen oxide occurrence on aggregation parameters of thrombocytes in patients with unstable angina at in vitro conditions.
Vyacheslav F. Kirichuk, Evgeny V. Andronov   +1 more
doaj  

Association of GLP‐1 Receptor Agonist Use With Cardiovascular Outcomes and Mortality in Japanese Patients With Type 2 Diabetes: A Real‐World Claims Database Study

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 10037-10044, November 2026.
ABSTRACT Aims Large‐scale clinical trials have shown multiple effects of glucagon‐like peptide 1 receptor agonists (GLP‐1RAs); however, similar evidence for Asian patients is limited. Therefore, using a Japanese large‐scale claims‐based database, the effects of GLP‐1RAs on cardiovascular and cerebrovascular events including mortality were compared with
Masaya Koshizaka, Ryoichi Ishibashi, Tomoki Ishikawa, Kazuo Goda, Jumpei Sato, Masaru Kitsuregawa, Koutaro Yokote, Naohiro Mitsutake   +7 more
wiley   +1 more source

GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial: Rationale, Design and Baseline Characteristics

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9861-9870, November 2026.
ABSTRACT Aims No studies have investigated the synergistic effectiveness of Glucagon‐Like Peptide 1 Receptor Agonists (GLP1RAs) in patients with persistent obesity following bariatric surgery. The GLP‐1 Receptor Agonists Post‐Bariatric Surgery (GRABS) Trial aims to investigate the effectiveness of tirzepatide (TRZ) versus standard of care (SOC) after ...
J. M. Samuels, C. R. Williams, M. B. Patel, W. H. Self, L. M. Funk, C. Roumie, M. D. Spann, C. J. Northup, F. Ye, R. Irlmeier, I. Sohn, Y. Zhu, K. Niswender   +12 more
wiley   +1 more source

Low Weight Loss Response to Incretin Analogs: A Systematic Review

Obesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT The development of GLP‐1 and GIP analogs has been a significant breakthrough in type 2 diabetes and obesity pharmacotherapy. However, individual responses to these medications can vary widely. This systematic review examines factors associated with low or no weight loss response to GLP‐1 and GIP analogs. Key predictors of poor response include
Pamela S. Gaskin, Peter S. Chami
wiley   +1 more source